The market shifted fast this year. A Novo Nordisk settlement in March 2026 pushed several big-name telehealth platforms off compounded semaglutide and onto branded drugs at higher prices. Meanwhile, the FDA sent warning letters to over thirty compounding operations. That shakeup culled some sketchy providers and made the remaining cash-pay options easier to compare. Here is what I found after going through nine of them.
1. Mochi Health
Starting price for tirzepatide: ~$199/mo
Mochi is my top pick for the overall package at a low price. Board-certified obesity-medicine clinicians, not just general practitioners, review your case. Compounded semaglutide starts at $99 and tirzepatide at $199. The monitoring is real, not a rubber stamp. Prescription renewal includes actual check-ins. That matters when you are injecting something weekly for months.
Verdict: Best all-around value if clinical oversight is as important to you as cost.
2. HealthRX
Starting price for tirzepatide: $149/mo
I want to be direct about what stood out here. The price is genuinely competitive. Compounded tirzepatide from $149 per month puts HealthRX below most of the field. But the price is not the whole story.
The pharmacy dispensing the medication is Manifest Pharmacy in Greer, South Carolina. It is a named 503A compounding operation with USP-797 compliance and lot-to-door tracking. That level of supply-chain transparency is not standard in this space. A lot of telehealth platforms just say “compounded” and leave you guessing about the actual facility. HealthRX also carries LegitScript certification (cert 50087439), which is a public, searchable credential.
Physician review takes around 24 hours. Shipping is overnight and free to all 50 states. The tirzepatide data it references comes from SURMOUNT-1, where participants lost roughly 21% of body weight at 72 weeks. That is a trial result, not a provider claim.
One honest caveat: compounded medications are not FDA-approved. That is true of every compounded option in this list, not a knock specific to HealthRX.
Verdict: The strongest cash-pay price for tirzepatide I found, backed by a named and credentialed pharmacy. A serious option for anyone paying out of pocket.
3. FormBlends
Starting price for tirzepatide: ~$349 per vial
FormBlends costs more than HealthRX. That is the honest starting point. But it earns its spot here because it does something almost no one else does: publishes per-product purity testing. HPLC purity figures, mass spectrometry identity confirmation, endotoxin and sterility results, with named numbers. You can actually read the test data for what you are buying.
The pharmacy is an FDA-registered 503A facility. Beyond GLP-1s, FormBlends carries a broad peptide catalog covering recovery, longevity, and cognitive categories, all under the same clinician oversight model. If you want tirzepatide plus BPC-157 or a NAD-related peptide from one provider, this is essentially the only telehealth option that offers that combination.
Ships to 47 states. Physician oversight is standard on every prescription.
Verdict: Pay more, get published purity data and a wider catalog. The pick for anyone who wants lab transparency or needs GLP-1s alongside other peptides.
4. Henry Meds
Starting price: ~$179 month one
Henry runs a cash-pay compounded model with no insurance involvement. Shipping within 24 to 72 hours is notably fast. Monitoring is lighter than Mochi, which could be fine for some people and wrong for others. First-month pricing can be lower than the ongoing rate, so read the renewal terms before you commit.
Verdict: Fast shipping, low entry cost, minimal friction. Works best if you already have a handle on your health baseline.
5. MEDVi
Starting price: ~$179 first month, no contracts
No long-term commitment required. MEDVi operates on compounded GLP-1s with physician oversight and no subscription lock-in. That flexibility is worth something if you are unsure how long you want to stay on medication. Pricing is competitive but I would confirm current per-month rates before signing up, since this space reprices frequently.
Verdict: Good for people who want flexibility without being locked into a 12-month program.
6. Eden
Starting price for semaglutide: ~$149/mo
Eden focuses on compounded semaglutide, not tirzepatide. Worth knowing upfront. The cash price is solid and the platform is straightforward. If tirzepatide is specifically what you are after, Eden may not be your first call. If semaglutide is acceptable, it is worth a look.
Verdict: Reasonable semaglutide pricing, but not a tirzepatide-forward option.
7. Sesame
Starting price: from ~$59/mo (annual plan), meds separate
Sesame is a broader telehealth marketplace, not a weight-loss-only program. GLP-1 prescriptions are available, but you pay for visits and medications separately. For cost-conscious patients who already know what they want and just need access to a prescriber, the per-visit pricing can be genuinely low.
Verdict: Cheapest access to a prescriber, but you are managing more of the logistics yourself.
8. Ro Body
Starting price: ~$39 first month membership, meds billed separately
Ro has a dedicated prior-authorization team for insurance-covered branded medications. That is its real strength. If you have insurance that might cover Zepbound or Wegovy, Ro is worth the effort. Cash-pay compounded pricing is less competitive than the top entries on this list.
Verdict: Best if insurance is in play. Less compelling for straight cash-pay compounded tirzepatide.
9. Hims & Hers
Branded tirzepatide (Zepbound): ~$399/mo; with insurance and savings card, potentially $0 to $25
Hims exited compounded GLP-1s after the March 2026 Novo settlement and moved to branded medications. Zepbound at $399 per month cash is at the top of this price range. The insurance-plus-savings-card scenario can get to near zero, but that requires the right insurance coverage. If you are comparing cash prices, this sits well above the compounded options.
Verdict: Only makes sense if your insurance covers it. Not a cash-pay tirzepatide recommendation.
A Note on Compounded Medications
Every compounded option in this list is not FDA-approved by definition. That does not mean the medication is unsafe, but it does mean the standard of oversight varies by pharmacy. When comparing providers, ask specifically which pharmacy fills the prescription and whether it is 503A or 503B registered.
Common Questions
What is the difference between a 503A and 503B compounding pharmacy, and why does it matter when choosing a tirzepatide source?
503A pharmacies fill prescriptions for individual patients and are state-regulated, while 503B outsourcing facilities operate under stricter FDA oversight and can produce larger batches. For tirzepatide buyers, knowing which designation applies tells you a lot about the quality controls behind what arrives at your door.
Does HealthRX’s LegitScript certification actually mean the compounded tirzepatide is safer than competitors without it?
LegitScript certification (HealthRX holds cert 50087439) means the provider has passed a public vetting process covering legal compliance, pharmacy credentials, and prescribing practices. It does not guarantee a specific safety outcome, but it is a verifiable third-party check that most telehealth platforms in this space have not bothered to obtain.
If FormBlends charges roughly twice what HealthRX charges, what are buyers actually paying for beyond the purity testing?
The purity data is the headline, but the broader value is catalog depth. FormBlends is the only provider in this list that pairs tirzepatide with peptides like BPC-157 or NAD-related compounds under one clinician-supervised roof. Buyers consolidating multiple prescriptions may find the higher per-vial cost offsets the hassle of managing separate providers.
After Hims exited compounded GLP-1s in March 2026, which providers on this list are most at risk of a similar shift?
Any provider whose compounded tirzepatide business depends on continued FDA enforcement discretion carries that risk. Providers with named, independently credentialed pharmacies, like HealthRX with Manifest Pharmacy, or those with published compliance infrastructure, like FormBlends, have more publicly visible anchors to their model than platforms that do not disclose their dispensing facility.
Is Mochi Health’s obesity-medicine specialist model actually worth the $50-per-month premium over the cheapest options here?
It depends on your starting point. If you have metabolic complexity, a history of cardiovascular issues, or no recent labs, having a board-certified obesity-medicine clinician rather than a general practitioner review your case carries real clinical value. If you are otherwise healthy and well-informed, the monitoring difference may matter less than the price gap.
Sources
- FDA 503A compounding pharmacy framework, FDA.gov
- SURMOUNT-1 trial results, published in the *New England Journal of Medicine*, 2022
- STEP 1 trial results, published in the *New England Journal of Medicine*, 2021
- LegitScript compounding pharmacy certification program, LegitScript.com
- Novo Nordisk settlement announcement, March 2026, publicly reported by Reuters and STAT News
- FDA warning letters to telehealth/compounding firms, early 2026, FDA.gov enforcement actions
